Current Advances and Future Prospects in Cancer Immunotherapeutics
| dc.authorid | 0000-0001-6392-0785 | |
| dc.authorid | 0000-0002-8116-1222 | |
| dc.contributor.author | Dede, Zeynep | |
| dc.contributor.author | Tumer, Kader | |
| dc.contributor.author | Kan, Tugce | |
| dc.contributor.author | Yucel, Burcu | |
| dc.date.accessioned | 2025-05-10T19:58:06Z | |
| dc.date.issued | 2023 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, cancer research has focused mainly on developing more effective treatments to reduce deaths from cancer. With a better understanding of the molecular mechanisms in cancer cells, advances in cancer treatment have evolved and changed. The main priority of research is to develop treatment modalities with the highest response rate and less side effects. In this context, immunotherapies have started a new era in cancer treatments. In this review, an overview of the future of next-generation treatment methods is presented by including the most preferred immunotherapy methods. | |
| dc.identifier.doi | 10.4274/MMJ.galenos.2023.29599 | |
| dc.identifier.endpage | 94 | |
| dc.identifier.issn | 2149-2042 | |
| dc.identifier.issn | 2149-4606 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 36974661 | |
| dc.identifier.scopus | 2-s2.0-85152703554 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 88 | |
| dc.identifier.trdizinid | 1170663 | |
| dc.identifier.uri | https://doi.org/10.4274/MMJ.galenos.2023.29599 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1170663 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/13415 | |
| dc.identifier.volume | 38 | |
| dc.identifier.wos | WOS:001109597700013 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Galenos Publ House | |
| dc.relation.ispartof | Medeniyet Medical Journal | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Cancer | |
| dc.subject | immunotherapy | |
| dc.subject | CAR-T-cell therapy | |
| dc.subject | monoclonal antibody | |
| dc.subject | mRNA vaccine | |
| dc.title | Current Advances and Future Prospects in Cancer Immunotherapeutics | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










